Page last updated: 2024-11-02

piracetam and Ataxia of Gait

piracetam has been researched along with Ataxia of Gait in 2 studies

Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.

Research Excerpts

ExcerptRelevanceReference
"He presented with severe myoclonus, which was resistant to conventional therapy and dramatically improved after administration of 12-18 gm/die piracetam."1.33Suppression of myoclonus in SCA2 by piracetam. ( Barbieri, F; de Falco, A; De Michele, G; De Rosa, A; Filla, A; Rinaldi, C; Striano, P; Striano, S; Tucci, T, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belcastro, V1
Costa, C1
Galletti, F1
Autuori, A1
Pierguidi, L1
Pisani, F1
Calabresi, P1
Parnetti, L1
De Rosa, A1
Striano, P1
Barbieri, F1
de Falco, A1
Rinaldi, C1
Tucci, T1
Striano, S1
Filla, A1
De Michele, G1

Trials

1 trial available for piracetam and Ataxia of Gait

ArticleYear
Levetiracetam in newly diagnosed late-onset post-stroke seizures: a prospective observational study.
    Epilepsy research, 2008, Volume: 82, Issue:2-3

    Topics: Aged; Aged, 80 and over; Aggression; Anticonvulsants; Brain Ischemia; Cardiovascular Agents; Drug In

2008

Other Studies

1 other study available for piracetam and Ataxia of Gait

ArticleYear
Suppression of myoclonus in SCA2 by piracetam.
    Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:1

    Topics: Adult; Ataxia; Ataxins; Dose-Response Relationship, Drug; Gait Ataxia; Humans; Infusions, Intravenou

2006